Dermatologic Therapy

Cutaneous and mucosal reactions to oncologic therapy
pp. 385-385(1)
Author: LACOUTURE, MARIO E.

Adverse cutaneous reactions secondary to tyrosine kinase inhibitors including imatinib mesylate, nilotinib, and dasatinib
pp. 386-395(10)
Authors: AMITAY-LAISH, IRIS; STEMMER, SALOMON M.; LACOUTURE, MARIO E.

Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib
pp. 396-400(5)
Authors: MCLELLAN, BETH; KERR, HOLLY

Dermatologic manifestations of cytotoxic therapy
pp. 401-410(10)
Authors: HUANG, VICTOR; ANADKAT, MILAN

Acute graft-versus-host disease following hematopoietic stem-cell transplantation
pp. 411-423(13)
Authors: HU, STEPHANIE W.; COTLIAR, JONATHAN

Management of cancer therapy-induced oral mucositis
pp. 424-431(8)
Authors: BARASCH, ANDREI; EPSTEIN, JOEL B.

Treatment of chemotherapy-induced alopecia
pp. 432-442(11)
Authors: YEAGER, CAROLINE E.; OLSEN, ELISE A.

Colchicine in the management of mucous membrane pemphigoid
pp. 443-445(3)
Authors: CHAIDEMENOS, GEORGIOS; SIDIROPOULOS, THEODOROS; KATSIOULA, PARASKEVOULA; KOUSSIDOU-EREMONDI, THALIA

Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment
pp. 446-451(6)
Authors: RENZO, LAURA DI; SARACENO, ROSITA; SCHIPANI, CATERINA; RIZZO, MARIAGIOVANNA; BIANCHI, ALESSIA; NOCE, ANNALISA; ESPOSITO, MARIA; TIBERTI, SERGIO; CHIMENTI, SERGIO; DE LORENZO, ANTONINO

Subungual exostosis treated with an in situ thin split-thickness toenail bed graft
pp. 452-454(3)
Authors: CHOI, CHANG-MIN; CHO, HEE-RYUNG; LEW, BARK-LYNN; SIM, WOO-YOUNG

Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up
pp. 455-461(7)
Authors: ROSSI, A.; CANTISANI, C.; SCARNò, M.; TRUCCHIA, A.; FORTUNA, M. C.; CALVIERI, S.